PUBLISHER: The Business Research Company | PRODUCT CODE: 1939236
PUBLISHER: The Business Research Company | PRODUCT CODE: 1939236
Anti-retropulsion devices are instruments utilized in medical procedures, particularly in urology, to prevent kidney stones or fragments from moving back up the ureter towards the kidney during lithotripsy or other stone removal procedures. These tools stabilize stones or fragments within the urinary tract, aiding their passage or extraction without causing obstruction or complications.
The primary types of anti-retropulsion devices include basket-type, balloon-type, and other specialized variants. Basket-type devices are specifically designed for urological procedures to capture and remove kidney stones or fragments. These devices find applications in ureteroscopy, lithotripsy, and are used in settings such as hospitals and ambulatory surgical centers.
Tariffs are impacting the anti-retropulsion devices market by increasing import costs for nitinol baskets, balloon catheters, polymer components, and precision wire systems sourced through global supply chains, leading to higher procurement costs for hospitals and ambulatory surgical centers. The effect is more significant in Asia-Pacific, Latin America, and Middle Eastern regions that rely heavily on imported basket-type and balloon-type devices used in ureteroscopy and lithotripsy procedures. However, tariffs are also encouraging localized manufacturing, regional assembly, and supplier diversification, which can strengthen domestic device production and enhance long-term supply stability across key product segments.
The anti-retropulsion devices market research report is one of a series of new reports from The Business Research Company that provides anti-retropulsion devices market statistics, including anti-retropulsion devices industry global market size, regional shares, competitors with a anti-retropulsion devices market share, detailed anti-retropulsion devices market segments, market trends and opportunities, and any further data you may need to thrive in the anti-retropulsion devices industry. This anti-retropulsion devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The anti-retropulsion devices market size has grown strongly in recent years. It will grow from $2.56 billion in 2025 to $2.75 billion in 2026 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to rising incidence of kidney stones and urolithiasis, increasing adoption of ureteroscopy and lithotripsy procedures, early availability of basket and balloon anti-retropulsion devices, growth in hospital-based urology surgery volumes, increasing focus on stone clearance efficiency.
The anti-retropulsion devices market size is expected to see strong growth in the next few years. It will grow to $3.51 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to rising demand for minimally invasive stone removal technologies, increasing use of disposable anti-retropulsion devices, growth in ambulatory stone treatment procedures, expanding development of specialized device designs for complex stones, increasing investments in urology care infrastructure. Major trends in the forecast period include rising preference for advanced anti-retropulsion devices to improve stone stabilization during lithotripsy, increasing utilization of basket and balloon-type devices to minimize proximal stone migration, growing clinical shift toward minimally invasive ureteroscopy-based stone management, expanding adoption of procedure-specific device designs for complex ureteral anatomies, increasing demand for disposable and single-use anti-retropulsion devices to reduce infection risk.
The increasing prevalence of chronic kidney disease is anticipated to drive the growth of the anti-retropulsion device market in the coming years. Chronic kidney disease encompasses a wide range of conditions that impair the structure and function of the kidneys. Factors such as poor dietary habits, sedentary lifestyles, obesity, smoking, and excessive alcohol consumption significantly contribute to the rising burden of renal disorders. Anti-retropulsion devices are employed to improve the effectiveness of urological procedures by preventing kidney stone fragments from migrating back toward the kidney during treatment. For example, in May 2024, according to the Centers for Disease Control and Prevention, a US-based public health agency, the prevalence of chronic kidney disease among adults in the United States was estimated at more than 14%, affecting approximately 35.5 million individuals, up from 13% in 2023. As a result, the growing prevalence of chronic kidney disease is expected to fuel the expansion of the anti-retropulsion device market.
Companies operating in the anti-retropulsion device market are emphasizing design enhancements and user-focused innovations, such as vacuum-assisted kidney stone removal devices, to improve clinical outcomes and reduce procedure durations. Vacuum-assisted kidney stone removal devices are medical instruments designed to increase the efficiency of urological procedures by using suction to capture and extract kidney stones from the urinary tract. For instance, in March 2024, Calyxo, Inc., a US-based medical device company focused on advancing care for patients with kidney stones, introduced the CVAC System. This comprehensive solution is designed for efficient and effective kidney stone removal by combining irrigation and vacuum aspiration to continuously clear stone fragments during and after laser lithotripsy, enabling physicians to achieve stone-free results.
In June 2024, The Medical City, a Philippines-based hospital, acquired the Lumenis Moses 2.0 machine for an undisclosed amount. The acquisition is intended to enhance The Medical City's urological service offerings by enabling advanced, minimally invasive treatment options for kidney stones and benign prostatic hyperplasia. It aims to improve patient outcomes through greater procedural precision, improved efficiency, and shorter recovery times. Lumenis Ltd. is an Israel-based company specializing in the development of anti-retropulsion devices.
Major companies operating in the anti-retropulsion devices market are Johnson & Johnson, Medtronic plc, Boston Scientific Corporation, Cook Medical Incorporated, KARL STORZ SE & Co KG, Coloplast A/S, ROCAMED SAM, Endotherapeutics Pty Ltd, Dornier MedTech GmbH, Accordion Medical LLC, Cogentix Medical Inc., NeoScope Inc, OTU Medical, Clarion Medical Technologies, Calyxo Inc, EMS Urology, Happiness Works Medical, PENTAX Medical, UROMED Kurt Drews KG, EndoTheia Inc, Maxer Endoscopy GmbH
North America was the largest region in the anti-retropulsion devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-retropulsion devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the anti-retropulsion devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The anti-retropulsion devices market consists of sales of retrieval baskets, ureteral access sheaths, and tipless nitinol stone baskets. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Anti-Retropulsion Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses anti-retropulsion devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for anti-retropulsion devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The anti-retropulsion devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.